Time perspective and quality of life among HIV-infected patients in the context of HAART

By Préau M.   Apostolidis T.   Francois C.   Raffi F.   Spire B.  

AIDS Care, Vol. 19, Iss. 4, 2007-04 ,pp. : 449-458

Routledge Ltd

Access to resources Recommend Favorite

The Use of Biomarkers for Assessing HAART-Associated Renal Toxicity in HIV-Infected Patients

By  

Current HIV Research, Vol. 10, Iss. 6, 2012-09 ,pp. : 521-531

Bentham Science Publishers

Access to resources Recommend Favorite

HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use

By Chander Geetanjali   Himelhoch Seth   Fleishman John   Hellinger James   Gaist Paul   Moore Richard   Gebo Kelly  

AIDS Care, Vol. 21, Iss. 5, 2009-05 ,pp. : 655-663

Routledge Ltd

Access to resources Recommend Favorite

CMV pp65 antigen testing is of limited utility in the diagnosis of concomitant CMV disease in HIV-infected patients in the HAART era

By Skiest D.J.   Crosby C.  

Journal of Clinical Virology, Vol. 28, Iss. 2, 2003-10 ,pp. : 203-213

Elsevier

Access to resources Recommend Favorite

HAART has No Major Impact on Hematological and Plasma Bilirubin Changes in HIV-Infected Patients with Congenital G-6-PD Deficiency

By  

Current HIV Research, Vol. 11, Iss. 3, 2013-04 ,pp. : 193-197

Bentham Science Publishers

Access to resources Recommend Favorite